Cargando…
Isobenzofuranone derivatives exhibit antileishmanial effect by inhibiting type II DNA topoisomerase and inducing host response
Leishmania, a protozoan parasite, causes a wide range of human diseases ranging from the localized self-healing cutaneous lesions to fatal visceral leishmaniasis. Toxicity of traditional first line drugs and emergence of drug-resistant strains have worsened the situation. DNA topoisomerase II in kin...
Autores principales: | Mishra, Amartya, Vinayagam, Jayaraman, Saha, Sourav, Chowdhury, Sayan, Roychowdhury, Somenath, Jaisankar, Parasuraman, Majumder, Hemanta K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186449/ https://www.ncbi.nlm.nih.gov/pubmed/25505614 http://dx.doi.org/10.1002/prp2.70 |
Ejemplares similares
-
Isobenzofuranone derivative JVPH3, an inhibitor of L. donovani topoisomerase II, disrupts mitochondrial architecture in trypanosomatid parasites
por: Chowdhury, Somenath Roy, et al.
Publicado: (2018) -
Development of Derivatives of 3, 3′-Diindolylmethane as Potent Leishmania donovani Bi-Subunit Topoisomerase IB Poisons
por: Roy, Amit, et al.
Publicado: (2011) -
The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice
por: Chowdhury, Sayan, et al.
Publicado: (2012) -
The Antileishmanial Potential of C-3 Functionalized Isobenzofuranones against Leishmania (Leishmania) Infantum Chagasi
por: Pereira, Wagner Luiz, et al.
Publicado: (2015) -
The therapeutic potential of novel isobenzofuranones against Naegleria fowleri
por: Rizo-Liendo, Aitor, et al.
Publicado: (2021)